Low-dose aspirin increases aspirin resistance in patients with coronary artery disease
- 1 July 2005
- journal article
- research article
- Published by Elsevier in American Journal Of Medicine
- Vol. 118 (7), 723-727
- https://doi.org/10.1016/j.amjmed.2005.03.041
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Relationship of Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary SyndromesJAMA, 2004
- Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side EffectsChest, 2004
- Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatmentJournal of the American College of Cardiology, 2004
- Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASAThe American Journal of Cardiology, 2003
- Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass SurgeryCirculation, 2003
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJournal of the American College of Cardiology, 2003
- Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery diseaseThrombosis Research, 2002
- Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular EventsCirculation, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Profile and prevalence of aspirin resistance in patients with cardiovascular diseaseThe American Journal of Cardiology, 2001